Sophie E. Berends
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value?
Journal: Drug discovery today
Published: October 08, 2024
Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial.
Journal: The Journal of dermatological treatment
Published: February 23, 2022
Population Pharmacokinetics of Infliximab in Children with Juvenile Idiopathic Arthritis.
Journal: Therapeutic drug monitoring
Published: April 22, 2021
Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patients.
Journal: The Journal of antimicrobial chemotherapy
Published: March 03, 2021
Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial.
Journal: Scandinavian journal of gastroenterology
Published: December 08, 2020
Modelling of the relationship between infliximab exposure, faecal calprotectin and endoscopic remission in patients with Crohn's disease.
Journal: British journal of clinical pharmacology
Published: February 04, 2020
Monitoring of Adalimumab Concentrations at Home in Patients with Inflammatory Bowel Disease Using Dried Blood Samples.
Journal: Therapeutic drug monitoring
Published: August 30, 2019
Therapeutic drug monitoring-based dosing of TNF inhibitors in inflammatory bowel disease: the way forward?
Journal: Expert review of clinical pharmacology
Published: July 16, 2019
Pharmacokinetics of golimumab in moderate to severe ulcerative colitis: the GO-KINETIC study.
Journal: Scandinavian journal of gastroenterology
Published: May 28, 2019
Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: April 17, 2019
Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.
Journal: Gastroenterology
Published: December 13, 2018
Dried blood samples can support monitoring of infliximab concentrations in patients with inflammatory bowel disease: A clinical validation.
Journal: British journal of clinical pharmacology
Published: October 18, 2018
Last Updated: 09/26/2026